Literature DB >> 10874013

In vitro bioactivation of N-hydroxy-2-amino-alpha-carboline.

R S King1, C H Teitel, F F Kadlubar.   

Abstract

2-Amino-alpha-carboline (A alpha C) is a mutagenic and carcinogenic heterocyclic amine present in foods cooked at high temperature and in cigarette smoke. The mutagenic activity of A alpha C is dependent upon metabolic activation to N-hydroxy-A alpha C (N-OH-A alpha C); however, the metabolism of N-OH-A alpha C has not been studied. We have synthesized 2-nitro-alpha-carboline and N-OH-A alpha C and have examined in vitro bioactivation of N-OH-A alpha C by human and rodent liver cytosolic sulfotransferase(s) and acetyltransferase(s) and by recombinant human N-acetyltransferases, NAT1 and NAT2. The sulfotransferase-dependent bioactivation of N-OH-A alpha C by human liver cytosol exhibited large inter-individual variation (0.5-75, n = 14) and was significantly higher than bioactivation of N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP). Correlation and inhibition studies suggested that the isoform of sulfotransferase primarily responsible for bioactivation of N-OH-A alpha C in human liver cytosol is SULT1A1. O-Acetyltransferase-dependent bioactivation of N-OH-A alpha C by human liver cytosol also exhibited large inter-individual variation (16-192, n = 18). In contrast to other N-hydroxy heterocyclic amines, which are primarily substrates only for NAT2, both NAT1 and NAT2 catalyzed bioactivation of N-OH-A alpha C. The rate of bioactivation of N-OH-A alpha C by both NAT1 and NAT2 was significantly higher than that for N-OH-PhIP. In rat and mouse liver cytosols, the level of sulfotransferase-dependent bioactivation of N-OH-A alpha C was similar to the level in the high sulfotransferase activity human liver cytosol. The level of O-acetyltransferase-dependent bioactivation of N-OH-A alpha C in rat liver cytosol was also comparable with that in the high acetyltransferase activity human liver cytosol. However, the level of O-acetyltransferase-dependent bioactivation of N-OH-A alpha C in mouse liver cytosol was comparable with that in the low acetyltransferase activity human liver cytosol. In contrast to N-OH-PhIP, bioactivation of N-OH-A alpha C was not inhibited by glutathione S-transferase activity; however, DNA binding of N-acetoxy-A alpha C was inhibited 20% in the presence of GSH. These results suggest that bioactivation of N-OH-A alpha C may be a significant source of DNA damage in human tissues after dietary exposure to AalphaC and that the relative contribution of each pathway to bioactivation or detoxification of N-OH-A alpha C differs significantly from other N-hydroxy heterocyclic or aromatic amines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10874013

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  23 in total

1.  Quantification of Hemoglobin and White Blood Cell DNA Adducts of the Tobacco Carcinogens 2-Amino-9H-pyrido[2,3-b]indole and 4-Aminobiphenyl Formed in Humans by Nanoflow Liquid Chromatography/Ion Trap Multistage Mass Spectrometry.

Authors:  Tingting Cai; Medjda Bellamri; Xun Ming; Woon-Puay Koh; Mimi C Yu; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2017-05-25       Impact factor: 3.739

2.  Metabolism of the Tobacco Carcinogen 2-Amino-9H-pyrido[2,3-b]indole (AαC) in Primary Human Hepatocytes.

Authors:  Medjda Bellamri; Ludovic Le Hegarat; Robert J Turesky; Sophie Langouët
Journal:  Chem Res Toxicol       Date:  2016-12-15       Impact factor: 3.739

3.  Sulfation of 4-hydroxy toremifene: individual variability, isoform specificity, and contribution to toremifene pharmacogenomics.

Authors:  Vineetha Koroth Edavana; Ishwori B Dhakal; Xinfeng Yu; Suzanne Williams; Susan Kadlubar
Journal:  Drug Metab Dispos       Date:  2012-03-20       Impact factor: 3.922

4.  UDP-glucuronosyltransferase-mediated metabolic activation of the tobacco carcinogen 2-amino-9H-pyrido[2,3-b]indole.

Authors:  Yijin Tang; David M LeMaster; Gwendoline Nauwelaërs; Dan Gu; Sophie Langouët; Robert J Turesky
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

5.  Evaluation of Tobacco Smoke and Diet as Sources of Exposure to Two Heterocyclic Aromatic Amines for the U.S. Population: NHANES 2013-2014.

Authors:  Li Zhang; Lanqing Wang; Yao Li; Yang Xia; Cindy M Chang; Baoyun Xia; Connie S Sosnoff; Brittany N Pine; B Rey deCastro; Benjamin C Blount
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10-01       Impact factor: 4.254

6.  Effect of MRP2 and MRP3 Polymorphisms on Anastrozole Glucuronidation and MRP2 and MRP3 Gene Expression in Normal Liver Samples.

Authors:  Vineetha Koroth Edavana; Rosalind B Penney; Aiwei Yao-Borengasser; Athena Starlard-Davenport; Ishwori B Dhakal; Susan Kadlubar
Journal:  Int J Cancer Res Mol Mech       Date:  2015-09-22

Review 7.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

8.  DNA adduct formation of 4-aminobiphenyl and heterocyclic aromatic amines in human hepatocytes.

Authors:  Gwendoline Nauwelaers; Erin E Bessette; Dan Gu; Yijin Tang; Julie Rageul; Valérie Fessard; Jian-Min Yuan; Mimi C Yu; Sophie Langouët; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2011-04-19       Impact factor: 3.739

9.  Inhibition of human phenol and estrogen sulfotransferase by certain non-steroidal anti-inflammatory agents.

Authors:  Roberta S King; Anasuya A Ghosh; Jinfang Wu
Journal:  Curr Drug Metab       Date:  2006-10       Impact factor: 3.731

10.  Measurement of the Heterocyclic Amines 2-Amino-9H-pyrido[2,3-b]indole and 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Urine: Effects of Cigarette Smoking.

Authors:  Dmitri Konorev; Joseph S Koopmeiners; Yijin Tang; Elizabeth A Franck Thompson; Joni A Jensen; Dorothy K Hatsukami; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2015-12-03       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.